i
This Document Has Been Replaced By: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2017 Update Clinical Practice Guideline
Superseded
This Document Has Been Replaced By: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2017 Update Clinical Practice Guideline
Preexposure prophylaxis for the prevention of HIV infection – 2014 : a clinical practice guideline
-
05/07/2014
Details:
-
Corporate Authors:
-
Description:This publication provides a comprehensive clinical practice guideline for the use of PrEP for the prevention of HIV infection in the United States. It incorporates and extends information provided in interim guidance for PrEP use with MSM, with heterosexually active adults, and with IDU (also called persons who injection drugs [PWID]). Currently, prescribing daily oral PrEP with TDF/FTC is recommended as one prevention option for MSM, heterosexual men, heterosexual women, and IDU at substantial risk of HIV acquisition. As the results of additional PrEP clinical trials and studies in these and other populations at risk of HIV acquisition become known, this guideline will be updated.
-
Subjects:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Pages in Document:67 numbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: